血管增殖性疾病中的细胞循环:潜在的干预措施和输送途径
1Division of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA.
Circulation
|May 23, 2001
概括
细胞循环抑制显示出预防和逆转动脉样硬化等疾病中的血管增殖的前景. 将这些发现转化为临床实践需要有针对性的输送,适当的细胞点和最小化的副作用.
科学领域:
- 心血管医学 心血管医学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化和静脉缩是显著的临床挑战,由光滑肌肉细胞增殖驱动.
- 细胞循环调节是控制细胞生长和血管增殖反应的关键因素.
研究的目的:
- 审查目前关于细胞循环的概念及其在血管增殖性疾病中的作用.
- 讨论治疗这些疾病的潜在干预措施,包括细胞循环抑制.
- 检查体外细胞循环抑制数据对临床应用的转化.
主要方法:
- 关于细胞循环调节及其目标的当前文献的综述.
- 讨论药物,遗传和物理方法用于细胞循环抑制.
- 对正在进行的涉及抗增殖剂的临床试验进行分析.
主要成果:
- 细胞循环抑制是一种逆转或预防血管增殖的潜在策略.
- 关键的挑战包括有针对性的输送,识别细胞点,改善治疗比率.
- 抗增殖疗法对未来的心血管疾病管理具有重大前景.
结论:
- 细胞循环抑制的有效临床转化需要解决传递,向和安全问题.
- 进一步的研究和临床试验对于利用抗增殖疗法的潜力至关重要.
- 细胞周期调制代表了血管扩散性疾病的有希望的治疗途径.
更多相关视频
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
10.5K
08:02Characterization of Blood Outgrowth Endothelial Cells BOEC from Porcine Peripheral Blood
Published on: January 6, 2022
1.8K
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
